Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling

Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/EnzalutamideversusAnti-androgen Receptor ASC-J9® Lead to PromotionversusSuppression of Prostate Cancer Metastasis

(2013) Tzu-Hua Lin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells

(2012) Kuo-Pao Lai et al.   AMERICAN JOURNAL OF PATHOLOGY

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

(2012) Kenneth J. Pienta et al.   INVESTIGATIONAL NEW DRUGS

Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy

(2011) Y. Sun et al.   CANCER RESEARCH

Phase II Study of Abiraterone Acetate in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Displaying Bone Flare Discordant with Serologic Response

(2011) C. J. Ryan et al.   CLINICAL CANCER RESEARCH

N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer

(2010) Karin Jennbacken et al.   ENDOCRINE-RELATED CANCER

Androgen depletion up-regulates cadherin-11 expression in prostate cancer

(2010) Yu-Chen Lee et al.   JOURNAL OF PATHOLOGY

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

(2010) Howard I Scher et al.   LANCET

DHT Selectively Reverses Smad3-Mediated/TGF-β-Induced Responses through Transcriptional Down-Regulation of Smad3 in Prostate Epithelial Cells

(2010) Kyung Song et al.   MOLECULAR ENDOCRINOLOGY

Androgen receptors are differentially expressed in Gleason patterns of prostate cancer and down-regulated in matched lymph node metastases

(2010) Achim Fleischmann et al.   PROSTATE

Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease

(2009) Michael J. Donovan et al.   BJU INTERNATIONAL

CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis

(2009) Jian Zhang et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-α expression

(2009) Jiann-Jyh Lai et al.   JOURNAL OF CLINICAL INVESTIGATION

Transcriptional regulation of theTGF-β1promoter by androgen receptor

(2008) Wei Qi et al.   BIOCHEMICAL JOURNAL

Divergent Effects of Castration on Prostate Cancer in TRAMP Mice: Possible Implications for Therapy

(2008) Y. Tang et al.   CLINICAL CANCER RESEARCH

Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer

(2008) Grace L. Lu-Yao   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cadherin-11 Promotes the Metastasis of Prostate Cancer Cells to Bone

(2008) K. Chu et al.   MOLECULAR CANCER RESEARCH

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

(2008) Y. Niu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA